中华实验外科杂志
中華實驗外科雜誌
중화실험외과잡지
CHINESE JOURNAL OF EXPERIMENTAL SURGERY
2013年
5期
897-900
,共4页
刘成珪%王永生%李源%程龙%叶巍%张凯伦
劉成珪%王永生%李源%程龍%葉巍%張凱倫
류성규%왕영생%리원%정룡%협외%장개륜
药物缓释%血管内皮生长因子%纳米纤维
藥物緩釋%血管內皮生長因子%納米纖維
약물완석%혈관내피생장인자%납미섬유
Drug release%Vascular endothelial growth factor%Nanofiber
目的 应用同轴静电纺丝的方法制备以聚己内酯(PCL)为壳层,血管内皮生长因子(VEGF)和牛血清蛋白(BSA)为芯的纳米纤维缓释载体,观察其体外缓释VEGF的特性,并检测释放VEGF的活性.方法 观察15~18 kV电压下制备出来的VEGF纳米纤维缓释载体的形貌结构特征,分别在第1、3、7、15、30天检测BSA和VEGF的释放量分别为BSA/PCL(17%、34%、38%、45%、56%),BSA/PCL-聚乙二醇(PEG)(30%、45%、80%、89%、92%),VEGF(5%、10%、20%、60%、90%),绘制时间-累积释放量曲线(%),检测释放VEGF的活性,并与新鲜的VEGF组和无VEGF组作为平行对照.结果 15、16、17、18 kV制备出来的同轴静电纺丝直径为分别为(282.00±43.57)、(199.13 ±32.87)、(182.00±27.74)、(159.00±36.33) nm.VEGF在30 d内逐渐释放,累积释放量98%,释放出来VEGF的生物学活性与新鲜的VEGF之间差异无统计学意义(P>0.05),与无VEGF之间差异有统计学意义(P<0.05).结论 运用同轴静电纺丝技术成功制备了以PCL为壳层,VEGF和BSA为芯的纳米纤维缓释载体,通过调整电压可以控制纳米纤维的直径,该载体还能够保持VEGF的生物学活性并持续释放,同时可以通过加入PEG来调节其释放量.
目的 應用同軸靜電紡絲的方法製備以聚己內酯(PCL)為殼層,血管內皮生長因子(VEGF)和牛血清蛋白(BSA)為芯的納米纖維緩釋載體,觀察其體外緩釋VEGF的特性,併檢測釋放VEGF的活性.方法 觀察15~18 kV電壓下製備齣來的VEGF納米纖維緩釋載體的形貌結構特徵,分彆在第1、3、7、15、30天檢測BSA和VEGF的釋放量分彆為BSA/PCL(17%、34%、38%、45%、56%),BSA/PCL-聚乙二醇(PEG)(30%、45%、80%、89%、92%),VEGF(5%、10%、20%、60%、90%),繪製時間-纍積釋放量麯線(%),檢測釋放VEGF的活性,併與新鮮的VEGF組和無VEGF組作為平行對照.結果 15、16、17、18 kV製備齣來的同軸靜電紡絲直徑為分彆為(282.00±43.57)、(199.13 ±32.87)、(182.00±27.74)、(159.00±36.33) nm.VEGF在30 d內逐漸釋放,纍積釋放量98%,釋放齣來VEGF的生物學活性與新鮮的VEGF之間差異無統計學意義(P>0.05),與無VEGF之間差異有統計學意義(P<0.05).結論 運用同軸靜電紡絲技術成功製備瞭以PCL為殼層,VEGF和BSA為芯的納米纖維緩釋載體,通過調整電壓可以控製納米纖維的直徑,該載體還能夠保持VEGF的生物學活性併持續釋放,同時可以通過加入PEG來調節其釋放量.
목적 응용동축정전방사적방법제비이취기내지(PCL)위각층,혈관내피생장인자(VEGF)화우혈청단백(BSA)위심적납미섬유완석재체,관찰기체외완석VEGF적특성,병검측석방VEGF적활성.방법 관찰15~18 kV전압하제비출래적VEGF납미섬유완석재체적형모결구특정,분별재제1、3、7、15、30천검측BSA화VEGF적석방량분별위BSA/PCL(17%、34%、38%、45%、56%),BSA/PCL-취을이순(PEG)(30%、45%、80%、89%、92%),VEGF(5%、10%、20%、60%、90%),회제시간-루적석방량곡선(%),검측석방VEGF적활성,병여신선적VEGF조화무VEGF조작위평행대조.결과 15、16、17、18 kV제비출래적동축정전방사직경위분별위(282.00±43.57)、(199.13 ±32.87)、(182.00±27.74)、(159.00±36.33) nm.VEGF재30 d내축점석방,루적석방량98%,석방출래VEGF적생물학활성여신선적VEGF지간차이무통계학의의(P>0.05),여무VEGF지간차이유통계학의의(P<0.05).결론 운용동축정전방사기술성공제비료이PCL위각층,VEGF화BSA위심적납미섬유완석재체,통과조정전압가이공제납미섬유적직경,해재체환능구보지VEGF적생물학활성병지속석방,동시가이통과가입PEG래조절기석방량.
Objective To construct coaxial electrospinning nanofibers with poly (ε-caprolaetone)(PCL) as the shell and BSA and vascular endothelial growth factor (VEGF) as the core,expore its ability for VEGF delivery in vitro,and examine the biological activity of VEGF released.Methods The morphology of VEGF coaxial electrospinning nanofibers was observed at the voltage from 15-18 kV.At 1st,3rd,7th,15th,and 30th day,bovine serum albumin (BSA)/PCL was 17%,34%,38%,45% and 56%,BSA/PCL-polyethyleneglycol (PEG) was 30%,45%,80%,89% and 92%,and VEGF release was 5%,10%,20%,60%,90%,respectively.The curve of time-cumulative release percentage was drawn.At last,the biological activity of VEGF released was tested.Results The diameters of nanofibers at the voltage of 15,16,17 and 18 kV were (282.00±43.57),(199.13 ±32.87),(182.00±27.74),(159.00 ±36.33) nm respectively.The VEGF was released gradually within 30 days,and the cumulative release percentage was almost 98%.The biological activity of the released VEGF has no significant difference from the fresh VEGF (P > 0.05),but significant difference from no-VEGF group (P < 0.05).Conclusion We construct the VEGF coaxial electrospinning nanofibers with PCL as the shell and BSA and VEGF as the core,and can change the diameter of nanofibers by adjusting the voltage.The nanofobers can retain biological activity of VEGF and release VEGF gradually,and can also adjust the releasing by adding PEG.